Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2026 Q1 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/6/2026 | 16,122 | 0.0% | 257,133 | 3/31/2026 |
| 2024 Q4 | 4/23/2025 | 2,635 | 0.0% | 140,150 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 2,981 | 0.0% | 153,881 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 4,270 | 0.0% | 164,308 | 6/30/2024 |
| 2024 Q1 | 4/30/2024 | 4,665 | 0.0% | 163,095 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 4,714 | 0.0% | 154,059 | 12/31/2023 |
| 2023 Q3 | 11/2/2023 | 4,140 | 0.0% | 154,059 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 5,494 | 0.0% | 154,059 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 3,913 | 0.0% | 154,059 | 3/31/2023 |
| 2022 Q4 | 2/8/2023 | 9,377 | 0.0% | 231,193 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 7,738 | 0.0% | 234,142 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 7,208 | 0.0% | 204,705 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 9,399 | 0.0% | 204,377 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 14,595 | 0.0% | 220,142 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 12,764 | 0.0% | 204,456 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 16,867 | 0.0% | 203,656 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 14,889 | 0.0% | 224,542 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 17,120 | 0.0% | 223,126 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 9,141 | 0.0% | 212,290 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 9,729 | 0.0% | 225,262 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 6,176 | 0.0% | 214,681 | 3/31/2020 |
| 2019 Q4 | 1/27/2020 | 20,934 | 0.0% | 330,029 | 12/31/2019 |